Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Oncology
Published: January 06, 2026
Trans-cytolemmal water exchange in prostate manifest via DCE-MRI.
Journal: Magma (New York, N.Y.)
Published: September 12, 2025
Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized High-Risk Prostate Cancer: Results From a Prospective Pilot Study.
Journal: American journal of clinical oncology
Published: October 30, 2024
BMI and BPH correlate with urinary microbiome diversity and lower urinary tract symptoms in men.
Journal: bioRxiv : the preprint server for biology
Published: January 03, 2024
Body mass index and benign prostatic hyperplasia correlate with urinary microbiome diversity and lower urinary tract symptoms in men.
Journal: Communications medicine
Published: October 30, 2023
Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial.
Journal: European urology
Published: November 07, 2022
Calibrated Regression Models Based on the Risk of Clinical Nodal Metastasis Should be Used as Decision Aids for Prostate Cancer Staging to Reduce Unnecessary Imaging.
Journal: Clinical genitourinary cancer
Published: March 28, 2022
The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521.
Journal: International journal of radiation oncology, biology, physics
Published: November 17, 2021
Metabolic activity diffusion imaging (MADI): II. Noninvasive, high-resolution human brain mapping of sodium pump flux and cell metrics.
Journal: NMR in biomedicine
Published: July 20, 2021
Last Updated: 09/26/2026